Mutation Analysis of the c-mos Gene in Ovarian Teratomas
Author Information
Author(s): KAF de Foy, SA Gayther, WH Colledge, S Crockett, IV Scott, MJ Evans, BAJ Ponder
Primary Institution: CRC Human Cancer Genetics Research Group, Addenbrooke's Hospital, Cambridge, UK
Hypothesis
Does the c-mos proto-oncogene have cancer-causing alterations in human ovarian teratomas?
Conclusion
Mutations in the coding region of the c-MOS gene do not play a significant role in the genesis of human ovarian teratomas.
Supporting Evidence
- Female transgenic mice lacking c-mos develop ovarian teratomas, suggesting c-mos may act as a tumor-suppressor gene.
- The study identified a previously reported polymorphism and a new silent variant in the c-MOS gene.
- No disease-causing alterations were predicted from the identified variants.
Takeaway
The study looked at a gene called c-mos in tumors from 20 women and found that it doesn't cause these tumors.
Methodology
DNA from 20 ovarian teratomas was analyzed using single-strand conformational analysis and heteroduplex analysis, with sequencing performed on 9 samples.
Limitations
The study did not analyze genetic alterations outside the c-MOS coding region that might affect gene expression.
Participant Demographics
The study involved human ovarian teratomas, but specific demographic details of participants are not provided.
Want to read the original?
Access the complete publication on the publisher's website